Literature DB >> 28539300

[Clinical outcomes of intravascular ultrasound in guiding the treatment of non-left main intermediate coronary lesions for patients with acute coronary syndrome].

Hong-Bin Liang1, Qian Guo, Xin-Lu Zhang, Xue-Wei Liu, Yong-Zhen Tang, Wei-Yu Chen, Yu-Qing Hou, Jian-Cheng Xiu.   

Abstract

OBJECTIVE: To evaluate the long-term clinical outcomes of intravascular ultrasound(IVUS) in guiding the treatment of non-left main intermediate coronary lesions for patients of acute coronary syndrome (ACS).
METHODS: A total of 25 patients with intermediate coronary lesions(stenosis of 40%-70%) confirmed by coronary angiography were performed with IVUS. When MLA≥4 mm2, we deferred the PCI treatment and performed optimal medical treatment (OMT). The patient were followed up for 12 month. The primary outcome was target vessel revascularization (TVR) and secondary outcome was major adverse cardiac events (MACEs).
RESULTS: A total of 25 lesions of 25 patients were examined by IVUS. 19(76%) lesions were attenuated plaque, 4(16%)were echo-lucent plaque, 2(8%) were calcified plaque. Most of the plaque (18/25, 72%) were eccentric. Positive remodeling was found in 20(80%) lesions and negative remodeling in 5(20%) lesions with meanremodeling index of 1.17=0.15. Thrombus was found in 1 case, accounting for 4%. The diameter stenosis, area stenosis, minimal lumen area and the reference diameter mea-sured by IVUS were larger than those measured by quantitative coronary angiography (all P<0.05). One patient with non-ST segment elevated myocardiac infarction was performed revascularization because MI attacked again, and 2 patients with Unstable angina were treated with OMT but they were still rehospitalization because of angina occurred repeatedly. The incidence of TVR was 4.00%, so as 16.00% of MACE.
CONCLUSION: IVUS can be used to guide the treatment of non-left main intermediate coronary lesions for patients of acute coronary syndrome.

Entities:  

Mesh:

Year:  2017        PMID: 28539300      PMCID: PMC6780465     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  20 in total

Review 1.  American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.

Authors:  G S Mintz; S E Nissen; W D Anderson; S R Bailey; R Erbel; P J Fitzgerald; F J Pinto; K Rosenfield; R J Siegel; E M Tuzcu; P G Yock
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

Review 2.  Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: a consensus statement of the Society of Cardiovascular Angiography and Interventions.

Authors:  Amir Lotfi; Allen Jeremias; William F Fearon; Marc D Feldman; Roxana Mehran; John C Messenger; Cindy L Grines; Larry S Dean; Morton J Kern; Lloyd W Klein
Journal:  Catheter Cardiovasc Interv       Date:  2013-11-13       Impact factor: 2.692

3.  Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve.

Authors:  C Briguori; A Anzuini; F Airoldi; G Gimelli; T Nishida; M Adamian; N Corvaja; C Di Mario; A Colombo
Journal:  Am J Cardiol       Date:  2001-01-15       Impact factor: 2.778

4.  Optimal intravascular ultrasound criteria for defining the functional significance of intermediate coronary stenosis: an international multicenter study.

Authors:  Jung-Kyu Han; Bon-Kwon Koo; Kyung-Woo Park; Itsik Ben-Dor; Ron Waksman; Augusto Pichard; Chang-Wook Nam; Joon-Hyung Doh; Naotaka Murata; Nobuhiro Tanaka; Chi-Hang Lee; Nieves Gonzalo; Javier Escaned; Marco A Costa; Takashi Kubo; Takashi Akasaka; Xinyang Hu; Jianan Wang; Hyoung-Mo Yang; Myung-Ho Yoon; Seung-Jea Tahk; Seunghyun Ma; Sue K Park; Hyo-Soo Kim
Journal:  Cardiology       Date:  2014-01-30       Impact factor: 1.869

5.  Correction.

Authors: 
Journal:  J Am Coll Cardiol       Date:  2015-02-23       Impact factor: 24.094

6.  Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction.

Authors:  Argyrios Ntalianis; Jan-Willem Sels; Giedrius Davidavicius; Nobuhiro Tanaka; Olivier Muller; Catalina Trana; Emanuele Barbato; Michalis Hamilos; Fabio Mangiacapra; Guy R Heyndrickx; William Wijns; Nico H J Pijls; Bernard De Bruyne
Journal:  JACC Cardiovasc Interv       Date:  2010-12       Impact factor: 11.195

7.  Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: comparison with stress myocardial perfusion imaging.

Authors:  T Nishioka; A M Amanullah; H Luo; H Berglund; C J Kim; T Nagai; N Hakamata; S Katsushika; A Uehata; B Takase; K Isojima; D S Berman; R J Siegel
Journal:  J Am Coll Cardiol       Date:  1999-06       Impact factor: 24.094

8.  Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention.

Authors:  Ruchira Glaser; Faith Selzer; David P Faxon; Warren K Laskey; Howard A Cohen; James Slater; Katherine M Detre; Robert L Wilensky
Journal:  Circulation       Date:  2004-12-27       Impact factor: 29.690

9.  Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction.

Authors:  Jun-ichi Kotani; Gary S Mintz; Marco T Castagna; Ellen Pinnow; Chalak O Berzingi; Anh B Bui; Augusto D Pichard; Lowell F Satler; William O Suddath; Ron Waksman; John R Laird; Kenneth M Kent; Neil J Weissman
Journal:  Circulation       Date:  2003-06-02       Impact factor: 29.690

10.  Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study).

Authors:  Haibo Jia; Jiannan Dai; Jingbo Hou; Lei Xing; Lijia Ma; Huimin Liu; Maoen Xu; Yuan Yao; Sining Hu; Erika Yamamoto; Hang Lee; Shaosong Zhang; Bo Yu; Ik-Kyung Jang
Journal:  Eur Heart J       Date:  2017-03-14       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.